| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/10/2003 | US20030069263 Prevention drug abruse; analgesics |
| 04/10/2003 | US20030069255 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 04/10/2003 | US20030069253 Compositions and methods for treating otic, ophthalmic and nasal infections |
| 04/10/2003 | US20030069235 Therapy for eye infections |
| 04/10/2003 | US20030069232 Topical treatment of ocular hypertension, glaucoma, ischemic retinopathy and age-related macular degeneration with ophthalmic formulation of dopamine antagonists |
| 04/10/2003 | US20030069217 Methods of prevention and treatment of ischemic damage |
| 04/10/2003 | US20030069213 Oral preparation |
| 04/10/2003 | US20030069211 Injectable pamidronate disodium |
| 04/10/2003 | US20030069207 Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/10/2003 | US20030069203 Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate |
| 04/10/2003 | US20030069202 Compositions, kits, and methods for promoting defined health benefits |
| 04/10/2003 | US20030069183 Lyophilized HGF preparations |
| 04/10/2003 | US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 04/10/2003 | US20030069173 Peptide-enhanced transfections |
| 04/10/2003 | US20030068812 Immune modulation device for use in animals |
| 04/10/2003 | US20030068407 A particulate formulation containing an oil of a vitamin, an oil containing one or more vitamin or a derivative, a gelling agent of vegetable origin having a glass transition point greater than 20 degree C. and a protein except gelatin |
| 04/10/2003 | US20030068392 Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant |
| 04/10/2003 | US20030068384 Polymeric drug formulations |
| 04/10/2003 | US20030068383 Time release nutritional supplement |
| 04/10/2003 | US20030068381 Induced phase transition method for the production of microparticles containing hydrophilic active agents |
| 04/10/2003 | US20030068378 Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of a sexual dysfunction active agent and a mucosal adhesion enhancer, wherein mucosal adhesion enhancer is a starch graft copolymer |
| 04/10/2003 | US20030068376 Mucoadhesive film made up of non-microbial hydrocolloids and an effective dose of nicotine dissolves when applied intraorally to release nicotine which is absorbed through the oramucosae and directly reaches systemic circulation |
| 04/10/2003 | US20030068375 Oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist, one or more pharmaceutically acceptable excipients, and a gelling agent |
| 04/10/2003 | US20030068374 Containing physiologically active compound slightly soluble in water, a component obtained by treating with water a polyvalent metal compound slightly soluble in water, and a biodegradable polymer; improved release-control, stability |
| 04/10/2003 | US20030068373 Immediate release tablet |
| 04/10/2003 | US20030068372 Nutritional composition |
| 04/10/2003 | US20030068371 Pharmaceutical formulation containing opioid agonist,opioid antagonist and gelling agent |
| 04/10/2003 | US20030068370 Comprising a therapeutically effective amount of a drug susceptible to abuse and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of dosage form |
| 04/10/2003 | US20030068369 Comprising plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising solid matrix of polymer which contains drug, sub-units being connected together in assembled dosage form by a weld |
| 04/10/2003 | US20030068368 Solid dosage form; superior disintegration, dissolution and compression characteristics |
| 04/10/2003 | US20030068367 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/10/2003 | US20030068366 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| 04/10/2003 | US20030068365 Compositions and methods for administration of active agents using liposome beads |
| 04/10/2003 | US20030068364 Pro-liposomal encapsulated preparations (iv) |
| 04/10/2003 | US20030068362 Methods and formulations for the delivery of pharmacologically active agents |
| 04/10/2003 | US20030068361 For treating hyperglycemia and related disorders |
| 04/10/2003 | US20030068360 DNA vaccines for farm animals, in particular bovines and porcines |
| 04/10/2003 | US20030068358 Preparation for oral administration |
| 04/10/2003 | US20030068356 Sequential drug delivery systems |
| 04/10/2003 | US20030068353 Sustained release micro-porous hollow fiber and method of manufacturing the same |
| 04/10/2003 | US20030068350 .1-6% of a hydrophobically modified, alkali-soluble copolymer thickener, .05-2% of a polysaccharide hydrocolloid or polyalkylene glycol, a neutralizing amount of alkali and the balance water |
| 04/10/2003 | US20030068341 Oil in water emulsion cream that has maxacalcitol present in both oil and water phases |
| 04/10/2003 | US20030068338 Pharmaceutical emulsions for retroviral protease inhibitors |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068331 Dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent |
| 04/10/2003 | US20030068288 Cosmetic powder pencil or powder chalk |
| 04/10/2003 | US20030068280 Treatment of respiratory diseases |
| 04/10/2003 | US20030068279 Dispersible pharmaceutical-based dry powder composition comprising a therapeutically effective amount of pharmaceutical in combination with a pharmaceutically acceptable carrier |
| 04/10/2003 | US20030068278 Administering fine powder of active material; measured aerosol |
| 04/10/2003 | US20030068277 Particles for inhalation having sustained release properties |
| 04/10/2003 | US20030068276 Dosage forms |
| 04/10/2003 | US20030068250 For contact lenses |
| 04/10/2003 | US20030066800 Enteric coatings for drugs; sustained rlease |
| 04/10/2003 | US20030066753 Stable taurolidine electrolyte solutions |
| 04/10/2003 | US20030066525 Pressurised metered dose inhalers (MDI) |
| 04/10/2003 | US20030066524 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 04/10/2003 | CA2722319A1 Water-in-oil emulsions with ethylene oxide groups, compostions, and methods |
| 04/10/2003 | CA2466020A1 Rsv gene expression vaccine |
| 04/10/2003 | CA2462802A1 Nutrient medium for maintaining neural cells in injured nervous system |
| 04/10/2003 | CA2462661A1 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | CA2462602A1 Double stranded rna as an adjuvant in vaccine compositions |
| 04/10/2003 | CA2462599A1 Storage-stable fibrinogen solutions |
| 04/10/2003 | CA2462596A1 Storage-stable human fibrinogen solutions |
| 04/10/2003 | CA2462593A1 Compositions for oral gene therapy and methods of using same |
| 04/10/2003 | CA2462275A1 Novel composition of carvedilol |
| 04/10/2003 | CA2462004A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/10/2003 | CA2461971A1 Encapsulated materials |
| 04/10/2003 | CA2461924A1 Vaccine |
| 04/10/2003 | CA2461874A1 Method for making an insert |
| 04/10/2003 | CA2461856A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/10/2003 | CA2461618A1 Ibuprofen salt emulsifiers and cream formulations containing same |
| 04/10/2003 | CA2461553A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods |
| 04/10/2003 | CA2460894A1 Press-coated fast-dissolving/disintegrating molded product |
| 04/10/2003 | CA2460486A1 Pseudopolymorphic forms of carvedilol |
| 04/10/2003 | CA2460167A1 Aqueous ecabet sodium solution preparation |
| 04/09/2003 | EP1300420A1 Cellulose powder |
| 04/09/2003 | EP1300394A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 04/09/2003 | EP1300160A1 Method of stabilizing preparation |
| 04/09/2003 | EP1300155A1 Enteric preparations containing physiologically active peptides |
| 04/09/2003 | EP1300152A1 Percutaneous absorption type steroid preparation for external use |
| 04/09/2003 | EP1300143A1 Patch containing 4-biphenylacetic acid |
| 04/09/2003 | EP1300141A1 Medical composition kit for treating lesioned abnormal tissue |
| 04/09/2003 | EP1300140A1 Long release matricial formulations of pirlindol hydrochloride |
| 04/09/2003 | EP1300139A2 Medicament excipient particles for tissue-specific application of a medicament |
| 04/09/2003 | EP1300084A2 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299494A2 Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| 04/09/2003 | EP1299424A1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299348A1 Compounds and compositions for delivering active agents |
| 04/09/2003 | EP1299287A1 Methods of producing a terminally sterilized topical patch preparation |
| 04/09/2003 | EP1299230A1 Substrates for powder deposition containing conductive domains |
| 04/09/2003 | EP1299157A1 Composition and applicator for topical substance delivery |
| 04/09/2003 | EP1299134A1 The use of honey in wound dressings |
| 04/09/2003 | EP1299124A2 Composition for aqueous stabilization of fat-soluble vitamins |
| 04/09/2003 | EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 04/09/2003 | EP1299122A2 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |